ENLV
Enlivex Therapeutics Ltd.
$1.05
$0.00(0.00%)
20
Overall
--
Value
18
Tech
23
Quality
Market Cap
$25.76M
Volume
66.18K
52W Range
$0.81 - $2.10
Target Price
$10.00
Key Metrics Overview
| Market Cap | $25.76M | P/E Ratio | N/A |
| 52W High | $2.10 | 52W Low | $0.81 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 18.6% |
| Overall Score | 20 | Value Score | -- |
| Quality Score | 23 | Technical Score | 18 |
Growth Analysis
| EPS Current Est | $-0.45 | EPS Next Est | $-0.57 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $1.05 | 0% | 66.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW